Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota

Verfasser / Beitragende:
[Pierre H. H. Schneeberger, Jean T. Coulibaly, Morgan Gueuning, Wendelin Moser, Bryan Coburn, Jürg E. Frey, Jennifer Keiser]
Ort, Verlag, Jahr:
2018
Enthalten in:
International journal for parasitology. Drugs and drug resistance, 8 (3), pp. 372-378
Format:
Artikel (online)
ID: 52874464X
LEADER naa a22 4500
001 52874464X
005 20180922060414.0
007 cr unu---uuuuu
008 180922s2018 xx s 000 0 eng
022 |a 2211-3207 
024 7 0 |a 10.1016/j.ijpddr.2018.07.001  |2 doi 
035 |a (EDOC)oai:edoc.unibas.ch:65029 
091 |a 30007544  |b pmid 
245 0 0 |a Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota  |h [Elektronische Daten]  |c [Pierre H. H. Schneeberger, Jean T. Coulibaly, Morgan Gueuning, Wendelin Moser, Bryan Coburn, Jürg E. Frey, Jennifer Keiser] 
520 3 |a Soil-transmitted helminths infect 1.5 billion people worldwide. Treatment with anthelminthics is the key intervention but interactions between anthelminthic agents and the gut microbiota have not yet been studied. In this study, the effects of four anthelminthic drugs and combinations (tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate) on the gut microbiota were assessed. From each hookworm infected adolescent, one stool sample was collected prior to treatment, 24 h post-treatment and 3 weeks post-treatment, and a total of 144 stool samples were analyzed. The gut bacterial composition was analyzed using 16S rRNA gene sequencing. Tribendimidine given alone or together with oxantel-pamoate, and the combination of albendazole and oxantel pamoate were not associated with any major changes in the taxonomic composition of the gut microbiota in this population, at both the short-term post-treatment (24 h) and long-term post-treatment (3 weeks) periods. A high abundance of the bacterial phylum Bacteroidetes was observed following administration of tribendimidine plus ivermectin 24 h after treatment, due predominantly to difference in abundance of the families Prevotellaceae and Candidatus homeothermaceae. This effect is transient and disappears three weeks after treatment. Higher abundance of Bacteroidetes predicts an increase in metabolic pathways involved in the synthesis of B vitamins. This study highlights a strong relationship between tribendimidine and ivermectin administration and the gut microbiota and additional studies assessing the functional aspects as well as potential health-associated outcomes of these interactions are required. 
700 1 |a Schneeberger  |D Pierre H. H.  |e joint author 
700 1 |a Coulibaly  |D Jean T.  |e joint author 
700 1 |a Gueuning  |D Morgan  |e joint author 
700 1 |a Moser  |D Wendelin  |e joint author 
700 1 |a Coburn  |D Bryan  |e joint author 
700 1 |a Frey  |D Jürg E.  |e joint author 
700 1 |a Keiser  |D Jennifer  |e joint author 
773 0 |t International journal for parasitology. Drugs and drug resistance  |g 8 (3), pp. 372-378  |x 2211-3207 
856 4 0 |u https://edoc.unibas.ch/65029/1/20180725115756_5b5849a4e3f46.pdf  |q text/html  |z WWW-Backlink auf das Repository 
908 |D 1  |a Article  |2 edoc 
909 7 |a PeerReviewed  |2 edoc peerstatus 
950 |B EDOC  |P 856  |E 40  |u https://edoc.unibas.ch/65029/1/20180725115756_5b5849a4e3f46.pdf  |q text/html  |z WWW-Backlink auf das Repository 
950 |B EDOC  |P 700  |E 1-  |a Schneeberger  |D Pierre H. H.  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Coulibaly  |D Jean T.  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Gueuning  |D Morgan  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Moser  |D Wendelin  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Coburn  |D Bryan  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Frey  |D Jürg E.  |e joint author 
950 |B EDOC  |P 700  |E 1-  |a Keiser  |D Jennifer  |e joint author 
950 |B EDOC  |P 773  |E 0-  |t International journal for parasitology. Drugs and drug resistance  |g 8 (3), pp. 372-378  |x 2211-3207 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B EDOC  |F EDOC  |b EDOC  |j Article